1. Home
  2. NCA vs PGEN Comparison

NCA vs PGEN Comparison

Compare NCA & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen California Municipal Value Fund

NCA

Nuveen California Municipal Value Fund

HOLD

Current Price

$8.80

Market Cap

300.3M

Sector

Finance

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.67

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCA
PGEN
Founded
1987
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
300.3M
1.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NCA
PGEN
Price
$8.80
$3.67
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.67
AVG Volume (30 Days)
59.6K
4.2M
Earning Date
01-01-0001
11-13-2025
Dividend Yield
3.92%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,309,000.00
Revenue This Year
N/A
$342.78
Revenue Next Year
N/A
$478.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
59.20
52 Week Low
$7.77
$0.65
52 Week High
$9.12
$5.23

Technical Indicators

Market Signals
Indicator
NCA
PGEN
Relative Strength Index (RSI) 33.84 48.12
Support Level $8.77 $3.42
Resistance Level $8.94 $3.75
Average True Range (ATR) 0.10 0.23
MACD -0.03 -0.02
Stochastic Oscillator 5.26 50.00

Price Performance

Historical Comparison
NCA
PGEN

About NCA Nuveen California Municipal Value Fund

Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: